ArticleFrontiers in immunology2023

Leveraging diverse cell-death related signature predicts the prognosis and immunotherapy response in renal clear cell carcinoma.

Zhengqi Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.